May 13, 2021 / 03:00PM GMT
Geoffrey Christopher Meacham - BofA Securities, Research Division - Research Analyst
Okay. Good morning. Welcome to the last day of the Bank of America Healthcare Conference. My name is Geoff Meacham. I'm the senior biopharma analyst here at BofA. I also have Alec Stranahan from my team with me as well.
We're thrilled to have the Moderna team with us today for a session, and speaking on behalf of Moderna, we have CFO, Dave Meline. We also have Lavina Talukdar, who is Head of Investor Relations. Welcome, guys.
David W. Meline - Moderna, Inc. - CFO & Principal Accounting Officer
Good morning.
Lavina Talukdar - Moderna, Inc. - Senior VP & Head of IR
Good morning.
Geoffrey Christopher Meacham - BofA Securities, Research Division - Research Analyst
Yes. So we'll kick it off with David just giving us a couple of high-level comments post the quarter and an update, and then we'll get right into questions for Alec.
David W. Meline -
Moderna Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 13, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers